Chs Pharma Inc.
Get Full AccessDescription
- CHS Pharma Inc. on Feb. 2013 acquired its Intellectual Property Portfolio from Florida Atlantic University and Hospital for Special Surgery. The IP portfolio is considered a platform technology and currently consists of 4 issued patents, 2 allowed, and 8 applications pending. The mentioned portfolio covers drug candidates for treatments of Actinic Keratosis (Basal and Squamous cell Carcinomas in EU patent), Dry Macular Degeneration, Myocardial Infarction, and Ischemic Stroke. CHS's corporate development strategy is to develop the drug candidates up to Phase II clinical studies and at that point in time either form a strategic partnership or license the technology to other pharmaceutical companies.
-
Headquarters: , , , United States
More -
Phone Number:
-
-
Employees:2
-
Revenue:$1 - 10M
-
Legal Name:Chs Pharma Inc.
-
Chs Pharma Inc.'s Social Media
-
Is this data correct?
-
| NAICS Code: 541713 |
Show More
Frequently Asked Questions regarding Chs Pharma Inc.
-
What is Chs Pharma Inc.'s Revenue?
Chs Pharma Inc.'s revenue is $1 - 10M
-
What is Chs Pharma Inc.'s NAICS code?
Chs Pharma Inc.'s NAICS code is 541713
-
How many employees are working in Chs Pharma Inc.
Chs Pharma Inc. has 2 employees
-
What is Chs Pharma Inc.'s Industry?
Chs Pharma Inc. is in the industry of Biotechnology

